Featured Posts
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Blog
FDA’s Moderna decision demonstrates how science and government are incompatible
Last week, the FDA announced that it would not be considering Moderna’s application for a new flu vaccine because the control group Moderna used…
Search Posts
Citation
FDA approval for “biogeneric” drugs
Newsletter
Hurricane Recovery, Union Politics and Disaster Insurance
Residents of the hurricane-ravaged Gulf Coast are being advised to avoid taps and drink only bottled water. Unions increase their spending on campaign advertisements and…
Op-Eds
Activists Hit the (Plastic) Bottle Again
Anti-chemical activists opened a new front in their jihad against the plastics chemical bisphenol-A (BPA) this week.
Op-Eds
CAFE Oh Nay, Standard Has Hurt
The Detroit auto industry is clearly a victim of CAFE. But it’s not the only victim, and it’s not even the most prominent one.
Newsletter
Stem Cells, Regulating Lawn Mowers and Standing up to the SEC
The National Academy of Sciences argues for continued use of embryonic stem cells. The Environmental Protection Agency requires that new gas-powered lawn mowers come with…
Newsletter
Economic Projections, Comcast Sues the FCC and Cholesterol Drugs
A new report from the Federal Reserve projects continued slow growth and a weak business climate. Comcast sues the Federal Communications Commission over…